We have had witnesses come before us and suggest that CEPA ought to require an alternatives-based approach, meaning that industry should be forced to identify safer alternatives, if one can be used, when there are toxicity issues with products that are currently being used. Would your organizations be supportive of that kind of approach? If you are not in a position to answer today, I would be happy to receive a written answer later on.
On November 17th, 2016. See this statement in context.